Furthermore, incorporating the adenosine pathway signature recently described by Fong et al, we observed a strong correlation between IL-6 expression in cancer cells and its associated adenosine signature using bulk-RNA-seq data for NSCLC from TCGA with a coefficient correlation of 0.65 (figure 2E). This evidence concerns the gene IL6 and cancer.